Pular para o conteúdo
Merck

Hsp90 modulates the stability of MLKL and is required for TNF-induced necroptosis.

Cell death & disease (2016-02-13)
X M Zhao, Z Chen, J B Zhao, P P Zhang, Y F Pu, S H Jiang, J J Hou, Y M Cui, X L Jia, S Q Zhang
RESUMO

The pseudokinase mixed lineage kinase domain-like protein (MLKL) is a key component of tumor necrosis factor (TNF)-induced necroptosis and plays a crucial role in necroptosis execution. However, the mechanisms that control MLKL activity are not completely understood. Here, we identify the molecular chaperone Hsp90 as a novel MLKL-interacting protein. We show that Hsp90 associates with MLKL and is required for MLKL stability. Moreover, we find that Hsp90 also regulates the stability of the upstream RIP3 kinase. Interference with Hsp90 function with the 17AAG inhibitor destabilizes MLKL and RIP3, resulting in their degradation by the proteasome pathway. Furthermore, we find that Hsp90 is required for TNF-stimulated necrosome assembly. Disruption of Hsp90 function prevents necrosome formation and strongly reduces MLKL phosphorylation and inhibits TNF-induced necroptosis. Consistent with a positive role of Hsp90 in necroptosis, coexpression of Hsp90 increases MLKL oligomerization and plasma membrane translocation and enhances MLKL-mediated necroptosis. Our findings demonstrate that an efficient necrotic response requires a functional Hsp90.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Triton X-114, laboratory grade
Sigma-Aldrich
Anti-MLKL Antibody, clone 3H1, clone 3H1, from rat
Sigma-Aldrich
Anti-Mouse IgG (whole molecule)−Alkaline Phosphatase antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution